Article thumbnail
Location of Repository

The impact of cell crowding and active cell movement on vascular tumour growth

By R. Betteridge, M. R. Owen, H. M. Byrne, T. Alarcon and P. K. Maini


A multiscale model for vascular tumour growth is presented which includes systems of ordinary differential equations for the cell cycle and regulation of apoptosis in individual cells, coupled to partial differential equations for the spatio-temporal dynamics of nutrient and key signalling chemicals. Furthermore, these subcellular and tissue layers are incorporated into a cellular automaton framework for cancerous and normal tissue with an embedded vascular network. The model is the extension of previous work and includes novel features such as cell movement and contact inhibition. We presented a detailed simulation study of the effects of these additions on the invasive behaviour of tumour cells and the tumour's response to chemotherapy. In particular, we find that cell movement alone increases the rate of tumour growth and expansion, but that increasing the tumour cell carrying capacity leads to the formation of less invasive dense hypoxic tumours containing fewer tumour cells. However, when an increased carrying capacity is combined with significant tumour cell movement, the tumour grows and spreads more rapidly, accompanied by large spatio-temporal fluctuations in hypoxia, and hence in the number of quiescent cells. Since, in the model, hypoxic/quiescent cells produce VEGF which stimulates vascular adaptation, such fluctuations can dramatically affect drug delivery and the degree of success of chemotherapy

Topics: Biology and other natural sciences
Year: 2006
DOI identifier: 10.3934/nhm.2006.1.515
OAI identifier:

Suggested articles


  1. (2003). A cellular automaton model for tumour growth in a heterogeneous environment.
  2. (2001). A cellular automaton model of early tumor growth and invasion: The effects of native tissue vascularity and increased anaerobic tumor metabolism.
  3. A history of the study of solid tumor growth: the contribution of mathematical modelling.
  4. (2005). A hybrid mathematical model of solid tumour invasion: the importance of cell adhesion.
  5. (2005). A mathematical model of Doxorubicin treatment efficacy on non-Hodgkin lymphoma: investigation of current protocol through theoretical modelling results.
  6. (2004). A mathematical model of the effects of hypoxia on the cell-cycle of normal and cancer cells
  7. (2005). A multiple scale model of tumour growth. Multiscale Model. Simul.
  8. (2000). A quantitative model for differential motility of gliomas in grey and white matter.
  9. (1996). A systems approach to cancer therapy,
  10. (1997). Aggregation, Blowup and Collapse: The ABC’s of generalized taxis.
  11. Angelis. Strategies of applied mathematics towards an immuno mathematical theory on tumors immune system interactions.
  12. Biomechanics: Circulation”, Second Edition,
  13. (2003). Cancer modelling and simulation. Chapman and Hall/CRC,
  14. (2006). Cancer regression in patients after transfer of genetically engineered lymphocytes, Science,
  15. (2000). Cancer: looking outside the genome.
  16. (2002). Cellular automaton models of tumor development: A critical review,
  17. (2001). Delivery of molecular and cellular medicine to solid tumours.
  18. Development and validation of computational models of cellular interaction.
  19. (2003). Fluid shear stress and the vascular endothelium: for better and for worse. Progress Biophys.
  20. (2003). Gawlinski.The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models.
  21. (2001). Hypoxia inhibits G1/S transition through regulation of p27 expression.
  22. Intracellular accumulation and mechanism of action of doxorubicin in a spatiotemporal tumor model.
  23. (2004). Kinetics of vascular normalisation by VEGFR2 blockade governs brain tumour response to radiation: Role of oxygenation, angiopoietin-1 and matrix metalloproteinases. doi
  24. (2002). Macrophages in gene therapy: cellular delivery vehicles and in vivo targets,
  25. Mathematical modeling of cancer: the future of prognosis and treatment.
  26. Mathematical modelling of capillary formation and development in tumour angiogenesis: penetration into the stroma.
  27. Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: Clinical implications and therapeutic targeting strategies.
  28. (2006). Mathematical modelling of radiotherapy strategies for early breast cancer.
  29. (2006). Mathematical modelling of the influence of blood rheological properties upon adaptive tumour-induced angiogenesis,
  30. Mathematical modelling of the use of macrophages as vehicles for drug delivery to hypoxic tumour sites.
  31. Mathematical models of avascular tumour growth: a review. SIAM Review (2006),(in press).
  32. (1998). Mathematical physiology.
  33. (2006). Metabolic changes during carcinogenesis: Potential impact on invasiveness,
  34. (2002). Modeling of avascular tumor growth with a hybrid cellular automaton.
  35. (2006). Modelling the effects of vasculature evolution on early brain tumour growth.
  36. (1972). Models for the growth of a solid tumour by diffusion.
  37. (2003). Molecular regulation of vessel maturation.
  38. morphogenesis, and burgers dynamics in blood vessel formation.
  39. Multiscale modelling and mathematical problems related to tumor evolution and medical therapy.
  40. (2006). Multiscale modelling of tumour growth and therapy: the influence of vessel normalisation on chemotherapy.
  41. (2005). Normalization of tumour vasculature: an emerging concept in antiangiogenic therapy,
  42. On the growth and stability of cell cultures and solid tumours.
  43. On the role of endothelial progenitor cells in tumour neovascularisation.
  44. (2004). Othmer Mathematical modelling of tumour-induced angiogenesis.
  45. (2001). p21Cip1 and p27Kip1 regulate cell cycle reentry after hypoxic stress but are not necessary for hypoxia-induced arrest.
  46. (2001). p27(Kip1): regulation and function of haploinsufficient tumour suppressor and its misregulation in cancer Exp.
  47. (2002). Quantifying efficacy of chemotherapy of brain tumors with homogeneous and heterogeneous drug delivery.
  48. (2001). Regulation of the eukariotic cell-cycle: molecular anatagonism, hysteresis, and irreversible transitions. doi
  49. (1998). Response of tumour cells to hypoxia: role of p53 and NFκβ.
  50. (1999). Stochastic simulation of benign avascular tumour growth using the Potts model.
  51. (1998). Structural adaptation and stability of microvascular networks: theory and simulations.
  52. Structural adaptation in normal and cancerous vasculature.
  53. (2001). Structural adaptation of microvascular networks: functional response to adaptive responses.
  54. Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumours: clinical implications. Cancer Res.
  55. (2000). The macrophage - a novel system to deliver gene therapy to pathological hypoxia,
  56. The role of acidity in solid tumour growth and invasion.
  57. Theoretical analysis of conjugate localization in two-step cancer chemotherapy
  58. (2004). Two steps forward in the treatment of colorectal cancer,
  59. (2006). Vascular network remodelling via vessel co-option, regression and growth in tumours. Preprint. Available from the arXiv/Q-Bio repository:
  60. (2004). Vascular normalisation by VEGFR2 blockade induces a pressure gradient accross the vasculature and improves drug penetration tumours. Cancer Res.
  61. (2000). Vascularspecific growth factors and blood vessel formation. doi
  62. (2003). Virtual and real brain tumors: using mathematical modeling to quantify glioma growth and invasion.
  63. (2004). Why do cancers have high aerobic glycolisis?.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.